BK Polyomavirus Hijacks Extracellular Vesicles for

BKPyV JCPyV MCPyV SV40 TSPyV en bloc transmission extracellular vesicles neutralizing antibodies polyomavirus quasienveloped virus

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
28 02 2020
Historique:
received: 31 10 2019
accepted: 17 12 2019
pubmed: 4 1 2020
medline: 4 9 2020
entrez: 4 1 2020
Statut: epublish

Résumé

Most people are asymptomatic carriers of the BK polyomavirus (BKPyV), but the mechanisms of persistence and immune evasion remain poorly understood. Furthermore, BKPyV is responsible for nephropathies in kidney transplant recipients. Unfortunately, the sole therapeutic option is to modulate immunosuppression, which increases the risk of transplant rejection. Using iodixanol density gradients, we observed that Vero and renal proximal tubular epithelial infected cells release two populations of infectious particles, one of which cosediments with extracellular vesicles (EVs). Electron microscopy confirmed that a single vesicle could traffic tens of viral particles. In contrast to naked virions, the EV-associated particles (eBKPyVs) were not able to agglutinate red blood cells and did not use cell surface sialylated glycans as an attachment factor, demonstrating that different entry pathways were involved for each type of infectious particle. However, we also observed that naked BKPyV and eBKPyV were equally sensitive to neutralization by the serum of a seropositive patient or commercially available polyvalent immunoglobulin preparations, which occurred at a postattachment step, after endocytosis. In conclusion, our work shows a new mechanism that likely plays a critical role during the primary infection and in the persistence, but also the reactivation, of BKPyV.

Identifiants

pubmed: 31896595
pii: JVI.01834-19
doi: 10.1128/JVI.01834-19
pmc: PMC7158717
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Handala et al.

Références

J Gen Virol. 1987 Mar;68 ( Pt 3):879-83
pubmed: 3029311
Trends Microbiol. 2014 Feb;22(2):59-64
pubmed: 24268716
Curr Opin Microbiol. 2016 Aug;32:77-81
pubmed: 27232382
J Clin Microbiol. 2010 Apr;48(4):1112-25
pubmed: 20107086
PLoS One. 2011;6(7):e22468
pubmed: 21799863
Virology. 2015 Jan 1;474:110-6
pubmed: 25463609
Nature. 2013 Apr 18;496(7445):367-71
pubmed: 23542590
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13081-6
pubmed: 25157142
J Gen Virol. 2014 Oct;95(Pt 10):2166-2175
pubmed: 24970738
PLoS Pathog. 2012;8(4):e1002650
pubmed: 22511874
J Virol. 2007 Nov;81(21):11798-808
pubmed: 17699578
Rev Med Virol. 2019 Jul;29(4):e2044
pubmed: 30958614
Cell Host Microbe. 2018 Aug 8;24(2):208-220.e8
pubmed: 30092198
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2970-2976
pubmed: 30126636
Sci Rep. 2018 May 25;8(1):8161
pubmed: 29802284
Viruses. 2017 Nov 03;9(11):
pubmed: 29099746
PLoS Pathog. 2013;9(10):e1003688
pubmed: 24130487
J Am Soc Nephrol. 2018 Jan;29(1):326-334
pubmed: 29042457
Open Biol. 2015 Aug;5(8):
pubmed: 26246492
Virology. 2004 Jun 1;323(2):182-8
pubmed: 15193914
Annu Rev Virol. 2014 Nov;1(1):539-60
pubmed: 26958733
Appl Microbiol. 1965 Nov;13(6):1040-1
pubmed: 4286246
mBio. 2019 May 28;10(3):
pubmed: 31138755
mBio. 2019 Apr 9;10(2):
pubmed: 30967463
J Virol. 2006 Feb;80(3):1361-6
pubmed: 16415013
J Virol. 2018 Sep 26;92(20):
pubmed: 30068652
Viruses. 2019 Feb 19;11(2):
pubmed: 30791409
J Gastroenterol. 2013 Feb;48(2):147-58
pubmed: 23104469
Semin Liver Dis. 2013 Feb;33(1):3-14
pubmed: 23564385
Virus Res. 2019 May;265:143-149
pubmed: 30928427
ACS Chem Biol. 2008 Dec 19;3(12):757-64
pubmed: 19053244
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
PLoS Pathog. 2014 Apr 10;10(4):e1004045
pubmed: 24722773
Clin Transplant. 2019 Sep;33(9):e13528
pubmed: 30859620
Cell. 2015 Feb 12;160(4):619-630
pubmed: 25679758
J Virol. 1989 May;63(5):2278-88
pubmed: 2539518

Auteurs

Lynda Handala (L)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.
Laboratoire de Virologie, Centre Hospitalier Universitaire, Amiens, France.

Emmanuelle Blanchard (E)

Plateforme IBiSA de Microscopie Electronique, Université de Tours et CHU de Tours, Tours, France.
INSERM U1259, Université de Tours et CHU de Tours, Tours, France.

Pierre-Ivan Raynal (PI)

Plateforme IBiSA de Microscopie Electronique, Université de Tours et CHU de Tours, Tours, France.

Philippe Roingeard (P)

Plateforme IBiSA de Microscopie Electronique, Université de Tours et CHU de Tours, Tours, France.
INSERM U1259, Université de Tours et CHU de Tours, Tours, France.

Virginie Morel (V)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.
Laboratoire de Virologie, Centre Hospitalier Universitaire, Amiens, France.

Véronique Descamps (V)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.
Laboratoire de Virologie, Centre Hospitalier Universitaire, Amiens, France.

Sandrine Castelain (S)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.
Laboratoire de Virologie, Centre Hospitalier Universitaire, Amiens, France.

Catherine Francois (C)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.
Laboratoire de Virologie, Centre Hospitalier Universitaire, Amiens, France.

Gilles Duverlie (G)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.
Laboratoire de Virologie, Centre Hospitalier Universitaire, Amiens, France.

Etienne Brochot (E)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France etienne.brochot@u-picardie.fr francois.helle@u-picardie.fr.
Laboratoire de Virologie, Centre Hospitalier Universitaire, Amiens, France.

Francois Helle (F)

EA4294, Agents Infectieux, Résistance et chimiothérapie (AGIR), Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France etienne.brochot@u-picardie.fr francois.helle@u-picardie.fr.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH